Drug Type Small molecule drug |
Synonyms JRA-003 |
Target |
Mechanism IKKα inhibitors(component of inhibitor of nuclear factor kappa B kinase complex inhibitors), IKKβ inhibitors(inhibitor of nuclear factor kappa B kinase subunit beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 21 May 2020 |